UFP Technologies Acquires Marble Medical
16 Luglio 2024 - 10:05PM
UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom
manufacturer of comprehensive solutions for medical devices,
sterile packaging, and other highly engineered custom products,
today announced the acquisition of Marble Medical. Founded in 1988
and headquartered in Tallahassee, FL, Marble Medical develops and
manufactures adhesive based medical components and single-use
devices.
“Adding Marble Medical’s adhesives expertise is
a great complement to our surgical robot drapes and stick to skin
device platforms,” said R. Jeffrey Bailly, chairman and CEO of UFP
Technologies. “Marble Medical is a 3M Preferred Converter, and
along with their precision die cutting capabilities, gives our
clients access to a broader range of innovative solutions
incorporating highly specialized adhesive technologies.”
“In addition, Marble Medical is a longstanding
partner to our DAS Medical operation, making them an excellent
overall fit into our MedTech business,” continued Bailly. “This
acquisition aligns with our strategic focus and provides valuable
technologies in multiple key markets to bring more value to our
client base. This expanded range of materials and capabilities will
also allow us to vertically integrate in many existing application
areas.
Joe Audie, Marble Medical’s president, stated,
“We are excited to join the UFP family and be part of such a fast
growing and dynamic company. UFP’s customer base, engineering
skills, vast resources, and global manufacturing footprint is
expected to help Marble accelerate growth by leveraging our
biocompatible adhesives expertise in adjacent areas such as
diagnostic patches, wound care, and other stick to skin
applications.”
About UFP Technologies,
Inc.
UFP Technologies is a designer and custom
manufacturer of comprehensive solutions for medical devices,
sterile packaging, and other highly engineered custom products. UFP
is an important link in the medical device supply chain and a
valued outsource partner to most of the top medical device
manufacturers in the world. The Company’s single-use and
single-patient devices and components are used in a wide range of
medical devices and packaging for minimally invasive surgery,
infection prevention, wound care, wearables, orthopedic soft goods,
and orthopedic implants.
Forward Looking Statements
This press release contains statements relating
to expected financial performance and/or future business prospects,
events and plans that are forward-looking statements. Such
statements include but are not limited to: the anticipated effects
on us of acquiring Marble Medical; statements regarding anticipated
advantages we expect to realize from the Marble Medical
acquisition; statements regarding anticipated advantages Marble
Medical expects to realize from our customer base, resources and
manufacturing footprint; anticipated trends in the different
markets in which we compete and expectations regarding customer
demand; expectations regarding our business opportunities; and
statements about our growth potential and strategies for growth.
Investors are cautioned that such forward-looking statements
involve risks and uncertainties that could adversely affect our
business and prospects, and otherwise cause actual results to
differ materially from those anticipated by such forward-looking
statements, including the risks that the Company will not realize
the anticipated benefits of the acquisition of Marble Medical due
to the inability of the Company to execute its business strategy,
Marble Medical integration strategy or otherwise as well as other
risks and uncertainties that are detailed in the documents we file
with the SEC. Accordingly, actual results may differ materially.
Readers are referred to the documents we file with the SEC,
specifically the last report on Form 10-K. The forward-looking
statements contained herein speak only of our expectations as of
the date of this press release. We expressly disclaim any
obligation or undertaking to release publicly any updates or
revisions to any such statement to reflect any change in our
expectations or any change in events, conditions, or circumstances
on which any such statement is based.
Contact: Ron Lataille978-234-0926, rlataille@ufpt.com
Grafico Azioni Ufp Technologies (NASDAQ:UFPT)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Ufp Technologies (NASDAQ:UFPT)
Storico
Da Gen 2024 a Gen 2025